Form 4: Arteris CFO Sells Shares Under 10b5-1 Plan

Arteris, Inc.'s CFO, Nicholas B. Hawkins, sold 5,638 shares of common stock for a weighted average price of $9.0328 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc. (AIP), reported a sale of common stock.
• The transaction involved the disposition of 5,638 shares of Arteris Common Stock.
• The shares were sold at a weighted average price of $9.0328 per share.
• Individual sale prices ranged from $9.00 to $9.27.
• The sale was executed on August 1, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
• Following this transaction, Mr. Hawkins beneficially owns 119,272 shares of Arteris Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the fact that it was conducted under a pre-arranged 10b5-1 plan mitigates concerns that it is based on new, adverse non-public information. It represents a planned liquidity event for the insider.

Positives

• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than a reactive one based on immediate non-public information.

Negatives

• An insider sale, even if pre-planned, reduces the insider's direct ownership in the company.

Risks

• No specific risks are detailed in this Form 4 beyond the inherent market risks associated with stock ownership.

Future Outlook

Not applicable as this filing is a disclosure of an insider stock transaction and does not contain forward-looking statements or guidance.

Industry Context

This filing is a standard insider transaction disclosure and does not provide information relevant to broader industry trends or competitor analysis.

Stakeholder Impact

• Shareholders: The sale by a key executive slightly reduces insider ownership, but the pre-planned nature via a 10b5-1 plan suggests it is not a signal of negative company performance or outlook.

Key Dates

Recommendation

The filing details a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial planning and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this specific filing does not provide new information to alter the investment thesis.

Keywords

Arteris, AIP, Nicholas B. Hawkins, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction, Corporate Officer